Loading BSD 13F portfolios...
Elite Manager Tracking
The Top 150 BSDs
Real-time 13F holding analysis for the industry's most influential institutional investors. Track conviction shifts, new entries, and structural exits.
Real-time 13F holding analysis for the industry's most influential institutional investors. Track conviction shifts, new entries, and structural exits.

Institutional Investor • Casdin Capital
Value
$1.6B
Stocks
40 Stocks
Turnover
0.0%
Top Holdings
RVMD(24.64%) RLAY(15.32%) GDXD(12.99%) BLFS(6.71%) ILMN(4.76%)
Investment philosophy details pending verification.
| Ticker | P/C | Company Name | Sector | Market Value | Shares | Weight | Chg Shares | % Chg |
|---|---|---|---|---|---|---|---|---|
| RVMD | None | Revolution Medicines, Inc. | Healthcare | $482.7M | 0 | 24.6% | 0 | No Change |
| RLAY | None | RELAY THERAPEUTICS INC | General | $300.0M | 0 | 15.3% | 0 | No Change |
| GDXD | None | GeneDx Holdings Corp | Industrials | $254.5M | 0 | 13.0% | 0 | No Change |
| BLFS | None | BioLife Solutions, Inc. | Healthcare | $131.5M | 0 | 6.7% | 0 | No Change |
| ILMN | None | Illumina, Inc. | Health Care | $93.2M | 0 | 4.8% | 0 | No Change |
| LAB | None | STANDARD BIOTOOLS INC | General | $73.0M | 0 | 3.7% | 0 | No Change |
| GTOS | None | Structure Therapeutics Inc. | General | $63.1M | 0 | 3.2% | 0 | No Change |
| DNLI | None | Denali Therapeutics Inc. | Health Care | $52.6M | 0 | 2.7% | 0 | No Change |
| NGNE | None | NEUROGENE INC | General | $48.6M | 0 | 2.5% | 0 | No Change |
| BEAM | None | Beam Therapeutics Inc. | Health Care | $46.3M | 0 | 2.4% | 0 | No Change |
| Ticker | Amount | % Chg | Weight | Status |
|---|---|---|---|---|
| No recent buys. | ||||
| Ticker | Amount | % Chg | Weight | Status |
|---|---|---|---|---|
| No recent sells. | ||||
| Sector | Stocks | Value | Exposure |
|---|---|---|---|
| General | 23 | $736.6M | 37.6% |
| Healthcare | 3 | $614.7M | 31.4% |
| Health Care | 13 | $352.9M | 18.0% |
| Industrials | 1 | $254.5M | 13.0% |